SCHEMBL7267672

SCHEMBL7267672

COC(=O)C(N=Cc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MIF P14174 5/20 0.48
KMT2A Q03164 3/20 0.45
NOS2 P35228 2/20 0.44
MEN1 O00255 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267667 1.00 MIF (0.48) MIFKMT2ANOS2MEN1SMN1; SMN2
SCHEMBL7267668 1.00 MIF (0.48) MIFKMT2ANOS2MEN1SMN1; SMN2
SCHEMBL2984290 0.90 KMT2A (0.51) MIFKMT2AMEN1NPC1RAB9A
SCHEMBL2984292 0.90 KMT2A (0.51) MIFKMT2AMEN1NPC1RAB9A
SCHEMBL10855787 0.90 KMT2A (0.51) MIFKMT2AMEN1NPC1RAB9A
SCHEMBL9734293 0.90 KMT2A (0.51) MIFKMT2AMEN1NPC1RAB9A
SCHEMBL1968128 0.86 KMT2A (0.46) MIFKMT2AMEN1SMN1; SMN2NPC1
SCHEMBL1968126 0.86 KMT2A (0.46) MIFKMT2AMEN1SMN1; SMN2NPC1
SCHEMBL10858256 0.82 MIF (0.59) MIFKMT2A
SCHEMBL10858254 0.82 MIF (0.59) MIFKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279937-B1 2-AMINOACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1991-10-09 EP disclosed
EP-0279937-A1 2-Aminoacetamide derivatives FISONS CORPORATION (US) 1988-08-31 EP disclosed